Guobang Pharma Ltd. (605507.SS)

CNY 20.45

(0.34%)

Operating Expenses Summary of Guobang Pharma Ltd.

  • Guobang Pharma Ltd.'s latest annual operating expenses in 2023 was 550.06 Million CNY , up 3.15% from previous year.
  • Guobang Pharma Ltd.'s latest quarterly operating expenses in 2024 Q3 was 168.99 Million CNY , up 10.24% from previous quarter.
  • Guobang Pharma Ltd. reported a annual operating expenses of 575.06 Million CNY in annual operating expenses 2022, up 20.06% from previous year.
  • Guobang Pharma Ltd. reported a annual operating expenses of 478.98 Million CNY in annual operating expenses 2021, up 13.81% from previous year.
  • Guobang Pharma Ltd. reported a quarterly operating expenses of 168.99 Million CNY for 2024 Q3, up 10.24% from previous quarter.
  • Guobang Pharma Ltd. reported a quarterly operating expenses of 168.18 Million CNY for 2024 Q2, up 25.82% from previous quarter.

Annual Operating Expenses Chart of Guobang Pharma Ltd. (2023 - 2017)

Historical Annual Operating Expenses of Guobang Pharma Ltd. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 550.06 Million CNY 3.15%
2022 575.06 Million CNY 20.06%
2021 478.98 Million CNY 13.81%
2020 420.85 Million CNY 6.66%
2019 394.57 Million CNY 11.54%
2018 353.75 Million CNY 12.75%
2017 313.76 Million CNY 0.0%

Peer Operating Expenses Comparison of Guobang Pharma Ltd.

Name Operating Expenses Operating Expenses Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.61 Billion CNY 88.074%
Yabao Pharmaceutical Group Co., Ltd 1.43 Billion CNY 61.744%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 9.06 Billion CNY 93.933%
Harbin Pharmaceutical Group Co., Ltd. 3.39 Billion CNY 83.784%
Tasly Pharmaceutical Group Co., Ltd 4.56 Billion CNY 87.953%
Zhejiang Medicine Co., Ltd. 2.14 Billion CNY 74.345%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2.52 Billion CNY 78.183%
Lionco Pharmaceutical Group Co.,Ltd. 235.93 Million CNY -133.142%
Humanwell Healthcare (Group) Co.,Ltd. 7.77 Billion CNY 92.926%
Ginwa Enterprise (Group) Inc. 473.93 Million CNY -16.063%
Joincare Pharmaceutical Group Industry Co.,Ltd. 6.84 Billion CNY 91.96%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 334.81 Million CNY -64.29%
China Animal Husbandry Industry Co., Ltd. 665.77 Million CNY 17.379%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 516.66 Million CNY -6.465%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.89 Billion CNY 85.881%
Shanghai Haoyuan Chemexpress Co., Ltd. 720.84 Million CNY 23.691%
Ningbo Menovo Pharmaceutical Co., Ltd. 323.95 Million CNY -69.795%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 904.15 Million CNY 39.162%
Chongqing Taiji Industry(Group) Co.,Ltd 6.47 Billion CNY 91.499%
HPGC Renmintongtai Pharmaceutical Corporation 586.72 Million CNY 6.247%
Nanjing Well Pharmaceutical Group Co.,Ltd. 195.02 Million CNY -182.046%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.58 Billion CNY 65.334%
Henan Lingrui Pharmaceutical Co., Ltd. 1.77 Billion CNY 68.936%
Shenzhen Chipscreen Biosciences Co., Ltd. 617.41 Million CNY 10.908%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.73 Billion CNY 68.35%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.04 Billion CNY 81.957%
Zhongzhu Healthcare Holding Co.,Ltd 281 Million CNY -95.753%
Beijing Tongrentang Co., Ltd 5.21 Billion CNY 89.462%
KPC Pharmaceuticals, Inc. 2.88 Billion CNY 80.927%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 679.56 Million CNY 19.057%
North China Pharmaceutical Company Ltd. 3.05 Billion CNY 82.005%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 4.1 Billion CNY 86.584%
Tibet Weixinkang Medicine Co., Ltd. 497.13 Million CNY -10.647%
China National Medicines Corporation Ltd. 1.04 Billion CNY 47.458%
Zhejiang Hisun Pharmaceutical Co., Ltd. 3.96 Billion CNY 86.122%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 859.39 Million CNY 35.994%
ChengDu ShengNuo Biotec Co.,Ltd. 196.27 Million CNY -180.259%
Dali Pharmaceuticalco.,Ltd 56.92 Million CNY -866.224%
Changchun BCHT Biotechnology Co. 1.08 Billion CNY 49.404%
Zhejiang Shengda Bio-Pharm Co., Ltd. 119.2 Million CNY -361.441%
Shanghai Jiaoda Onlly Co.,Ltd 92.17 Million CNY -496.735%
Jiang Zhong Pharmaceutical Co.,Ltd 1.97 Billion CNY 72.12%
Mayinglong Pharmaceutical Group Co., LTD. 778.04 Million CNY 29.301%
Cisen Pharmaceutical Co., Ltd. 2.01 Billion CNY 72.7%
Hunan Warrant Pharmaceutical Co.,Ltd 691.12 Million CNY 20.41%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 17.16 Billion CNY 96.795%
Jianmin Pharmaceutical Group Co.,Ltd. 1.56 Billion CNY 64.937%
Hunan Fangsheng Pharmaceutical Co., Ltd. 912.55 Million CNY 39.723%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.77 Billion CNY 68.928%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 245.55 Million CNY -124.011%
Kangmei Pharmaceutical Co., Ltd. 628.4 Million CNY 12.467%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.48 Billion CNY 93.52%
Zhejiang Starry Pharmaceutical Co.,Ltd. 484.13 Million CNY -13.618%
Henan Taloph Pharmaceutical Stock Co.,Ltd 520.55 Million CNY -5.669%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.28 Billion CNY 57.353%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.19 Billion CNY 74.967%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 334.18 Million CNY -64.598%
Shanghai Shyndec Pharmaceutical Co., Ltd. 3.54 Billion CNY 84.48%
Shanghai Yizhong Pharmaceutical Co., Ltd. 175.02 Million CNY -214.277%
Tibet Rhodiola Pharmaceutical Holding Co. 2.07 Billion CNY 73.511%
Sichuan Huiyu Pharmaceutical Co., Ltd. 672.26 Million CNY 18.177%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 249.26 Million CNY -120.676%
CanSino Biologics Inc. 1.49 Billion CNY 63.15%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 869.22 Million CNY 36.718%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.18 Billion CNY 53.723%